M
2.41
-0.12 (-4.74%)
前收盘价格 | 2.53 |
收盘价格 | 2.50 |
成交量 | 71,517 |
平均成交量 (3个月) | 657,176 |
市值 | 86,007,840 |
价格/销量 (P/S) | 243.53 |
股市价格/股市净资产 (P/B) | 8.61 |
52周波幅 | |
利润日期 | 13 Aug 2025 - 17 Aug 2025 |
稀释每股收益 (EPS TTM) | -0.500 |
总债务/股东权益 (D/E MRQ) | 2.83% |
流动比率 (MRQ) | 7.00 |
营业现金流 (OCF TTM) | -12.63 M |
杠杆自由现金流 (LFCF TTM) | -7.96 M |
资产报酬率 (ROA TTM) | -67.36% |
股东权益报酬率 (ROE TTM) | -146.09% |
市场趋势
短期 | 中期 | ||
行业 | Medical Devices (US) | 看跌 | 看跌 |
Medical Devices (全球的) | 看跌 | 看跌 | |
股票 | Monogram Technologies Inc. | 混合的 | - |
AIStockmoo 评分
-0.6
分析师共识 | -2.0 |
内部交易活动 | NA |
价格波动 | -2.0 |
技术平均移动指标 | -2.5 |
技术振荡指标 | 4.0 |
平均 | -0.63 |
Monogram Technologies Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. |
|
部门 | Healthcare |
行业 | Medical Devices |
内部持股比例 | 33.52% |
机构持股比例 | 5.15% |
所有权
姓名 | 日期 | 持有股份 |
---|---|---|
Focus Partners Advisor Solutions, Llc | 31 Mar 2025 | 213,678 |
New Harbor Financial Group, Llc | 31 Mar 2025 | 29,348 |
Orion Portfolio Solutions, Llc | 31 Mar 2025 | 25,000 |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。
投资组合